CAR and PXR agonists stimulate hepatic bile acid and bilirubin detoxification and elimination pathways in mice†

The human orphan nuclear receptor PXR is activated by compounds that regulate CYP3A4 gene expression and cause drug interactions.

Lehmann, J., McKee, D. D., Watson, M. A., Willson, T. M., Moore, J. T., & Kliewer, S. A. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3703 · Cited by 1,577 · see citing works

Bile salt transporters: molecular characterization, function, and regulation

Trauner, M., & Boyer, J. L. (2003) · Physiological Reviews · doi:10.1152/physrev.00027.2002 · Cited by 999 · see citing works

Orphan Nuclear Receptors Constitutive Androstane Receptor and Pregnane X Receptor Share Xenobiotic and Steroid Ligands

Moore, L. B., Parks, D. J., Jones, S. A., Bledsoe, R. K., Consler, T. G., Stimmel, J. B., Goodwin, B. J., Liddle, C., Blanchard, S. G., Willson, T. M., et al. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001215200 · Cited by 818 · see citing works

Molecular Pathogenesis of Cholestasis

Trauner, M. A., Meier, P. J., & Boyer, J. L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391707 · Cited by 701 · see citing works

Molecular Pathogenesis of Cholestasis

Trauner, M. A., & Jansen, P. L. M. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9034-1 · Cited by 612 · see citing works

Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice

Fickert, P., Fuchsbichler, A., Wagner, M., Zollner, G., Kaser, A., Tilg, H., Krause, R. G. E., Lammert, F., Langner, C., Zatloukal, K., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.04.009 · Cited by 468 · see citing works

Diverse Roles of the Nuclear Orphan Receptor CAR in Regulating Hepatic Genes in Response to Phenobarbital

Ueda, A., Hamadeh, H. K., Webb, H. K., Yamamoto, Y., Sueyoshi, T., Afshari, C. A., Lehmann, J. M., & Negishi, M. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.1.1 · Cited by 465 · see citing works

Identification of a Novel Human Constitutive Androstane Receptor (CAR) Agonist and Its Use in the Identification of CAR Target Genes

Maglich, J. M., Parks, D. J., Moore, L. B., Collins, J. L., Goodwin, B. J., Billin, A. N., Stoltz, C. M., Kliewer, S. A., Lambert, M. H., Willson, T. M., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300138200 · Cited by 420 · see citing works

Induction of bilirubin clearance by the constitutive androstane receptor (CAR)

Huang, W., Zhang, J., Chua, S. S., Qatanani, M., Han, Y., Granata, R., & Moore, D. D. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630614100 · Cited by 390 · see citing works

Bile Acids: The Good, the Bad, and the Ugly

Hofmann, A. F. (1999) · Physiology · doi:10.1152/physiologyonline.1999.14.1.24 · Cited by 376 · see citing works

Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor

Xie, W., Yeuh, M.-F., Radominska-p, A., Saini, S. P. S., Negishi, Y., Bottroff, B. S., Cabrera, G. Y., Tukey, R. H., & Evans, R. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0438010100 · Cited by 367 · see citing works

Targeted inactivation of sister of P-glycoprotein gene ( spgp ) in mice results in nonprogressive but persistent intrahepatic cholestasis

Wang, R., Salem, M., Yousef, I. M., Tuchweber, B., Lam, P., Childs, S. J., Helgason, C. D., Ackerley, C. A., Phillips, M. J., & Ling, V. W. T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.2011 · Cited by 333 · see citing works

Complementary roles of farnesoid X receptor, pregnane X receptor, and constitutive androstane receptor in protection against bile acid toxicity

Guo, G. L., Lambert, G., Negishi, M., Ward, J. M., Brewer, H. B., Kliewer, S. A., Gonzalez, F. J., & Sinal, C. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307145200 · Cited by 312 · see citing works

Steroid and bile acid conjugates are substrates of human multidrug-resistance protein (MRP) 4 (ATP-binding cassette C4)

Zelcer, N., Reid, G., Wielinga, P. R., Kuil, A., van der Heijden, I., Schuetz, J. D., & Borst, P. (2003) · Biochemical Journal · doi:10.1042/bj20021886 · Cited by 312 · see citing works

Ursodeoxycholic acid aggravates bile infarcts in bile duct–ligated and Mdr2 knockout mice via disruption of cholangioles

Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Weiglein, A. H., Lammert, F., Marschall, H., Tsybrovskyy, O., Zatloukal, K., Denk, H., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.35948 · Cited by 312 · see citing works

Up–Regulation of Basolateral Multidrug Resistance Protein 3 (Mrp3) in Cholestatic Rat Liver

Donner, M. G., & KEPPLER, D. O. R. (2001) · Hepatology · doi:10.1053/jhep.2001.26213 · Cited by 291 · see citing works

Cellular Localization and Up–Regulation of Multidrug Resistance-Associated Protein 3 in Hepatocytes and Cholangiocytes During Obstructive Cholestasis in Rat Liver

Soroka, C. J., Lee, J. M., Azzaroli, F., & Boyer, J. L. (2001) · Hepatology · doi:10.1053/jhep.2001.23501 · Cited by 288 · see citing works

Adaptive changes in hepatobiliary transporter expression in primary biliary cirrhosis

Zollner, G., Fickert, P., Silbert, D., Fuchsbichler, A., Marschall, H., Zatloukal, K., Denk, H., & Trauner, M. A. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00096-5 · Cited by 275 · see citing works

Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice

Wagner, M., Fickert, P., Zollner, G., Fuchsbichler, A., Silbert, D., Tsybrovskyy, O., Zatloukal, K., Guo, G. L., Schuetz, J. D., Gonzalez, F. J., et al. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)01068-0 · Cited by 264 · see citing works

Effects of Ursodeoxycholic and Cholic Acid Feeding on Hepatocellular Transporter Expression in Mouse Liver

Fickert, P., Zollner, G., Fuchsbichler, A., Stumptner, C., Pojer, C., Zenz, R., Lammert, F., Stieger, B., Meier, P. J., Zatloukal, K., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.25542 · Cited by 257 · see citing works

Oatp2 Mediates Bidirectional Organic Solute Transport: A Role for Intracellular Glutathione

Li, L., Meier, P. J., & Ballatori, N. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.2.335 · Cited by 222 · see citing works

Localization and function of the organic anion–transporting polypeptide Oatp2 in rat liver

Reichel, C., Gao, B., van Montfoort, J. E., Cattori, V., Rahner, C., Hagenbuch, B., Stieger, B., Kamisako, T., & Meier, P. J. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70463-4 · Cited by 210 · see citing works

Increased Hepatobiliary and Fecal Cholesterol Excretion upon Activation of the Liver X Receptor Is Independent of ABCA1

Plösch, T., Kok, T., Bloks, V. W., Smit, M. J., Havinga, R., Chimini, G., Groen, A. K., & Kuipers, F. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206522200 · Cited by 207 · see citing works

Mechanism of phenobarbital-induced hypercholeresis in the rat

Berthelot, P., Erlinger, S., Dhumeaux, D., & Am, P. (1970) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1970.219.3.809 · Cited by 207 · see citing works

Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis

Prince, M. I., Burt, A. D., & Jones, D. E. J. (2002) · Gut · doi:10.1136/gut.50.3.436 · Cited by 202 · see citing works

Role of nuclear bile acid receptor, FXR, in adaptive ABC transporter regulation by cholic and ursodeoxycholic acid in mouse liver, kidney and intestine

Zollner, G., Fickert, P., Fuchsbichler, A., Silbert, D., Wagner, M., Arbeiter, S., Gonzalez, F. J., Marschall, H., Zatloukal, K., Denk, H., et al. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00228-9 · Cited by 193 · see citing works

Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis.

Henegouwen, G. P. V. B., Brandt, K. H., Eyssen, H., & Parmentier, G. G. (1976) · Gut · doi:10.1136/gut.17.11.861 · Cited by 172 · see citing works

Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat

Lee, J., Azzaroli, F., Wang, L., Soroka, C. J., Gigliozzi, A., Setchell, K. D. R., Kramer, W., & Boyer, J. L. (2001) · Gastroenterology · doi:10.1053/gast.2001.29608 · Cited by 166 · see citing works

Molecular Regulation of Hepatobiliary Transport Systems

Trauner, M. A., Wagner, M., Fickert, P., & Zollner, G. (2005) · Journal of Clinical Gastroenterology · doi:10.1097/01.mcg.0000155551.37266.26 · Cited by 162 · see citing works

Peroxisome proliferator-activated receptor alpha (PPARalpha)-mediated regulation of multidrug resistance 2 (Mdr2) expression and function in mice

Kok, T., Bloks, V. W., Wolters, H., Havinga, R., Jansen, P. L. M., Staels, B., & Kuipers, F. (2003) · Biochemical Journal · doi:10.1042/bj20020981 · Cited by 161 · see citing works

Bile acid profiles in urine of patients with liver diseases

Bremmelgaard, A., & Sjövall, J. (1979) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1979.tb00894.x · Cited by 153 · see citing works

Tumor Necrosis Factor α-dependent Up-regulation of Lrh-1 and Mrp3(Abcc3) Reduces Liver Injury in Obstructive Cholestasis

Bohan, A., Chen, W., Denson, L. A., Held, M. A., & Boyer, J. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304011200 · Cited by 151 · see citing works

Protective Role of Hydroxysteroid Sulfotransferase in Lithocholic Acid-induced Liver Toxicity

Kitada, H., Miyata, M., Nakamura, T., Tozawa, A., Honma, W., Shimada, M., Nagata, K., Sinal, C. J., Guo, G. L., Gonzalez, F. J., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210634200 · Cited by 151 · see citing works

Molecular Alterations in Hepatocyte Transport Mechanisms in Acquired Cholestatic Liver Disorders

LEE, J., & Boyer, J. L. (2000) · Seminars in Liver Disease · doi:10.1055/s-2000-9390 · Cited by 121 · see citing works

Human Apical Sodium-dependent Bile Salt Transporter Gene (SLC10A2) Is Regulated by the Peroxisome Proliferator-activated Receptor α

Jung, D., Fried, M., & Kullak-Ublick, G. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203511200 · Cited by 110 · see citing works

Primate Biliary Physiology VIII. THE EFFECT OF PHENOBARBITAL UPON BILE SALT SYNTHESIS AND POOL SIZE, BILIARY LIPID SECRETION, AND BILE COMPOSITION

Redinger, R. N., & SMALL, D. M. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107160 · Cited by 95 · see citing works

Statin Induction of Liver Fatty Acid-Binding Protein (L-FABP) Gene Expression Is Peroxisome Proliferator-activated Receptor-α-dependent

Landrier, J., Thomas, C., Grober, J., Duez, H., Percevault, F., Souidi, M., Linard, C., Staels, B., & Besnard, P. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407461200 · Cited by 94 · see citing works

Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers

Ritzel, U., Leonhardt, U., Näther, M., Schäfer, G., Armstrong, V. W., & Ramadori, G. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00006-5 · Cited by 94 · see citing works

3-hydroxy-3-methylglutaryl–coenzyme a reductase inhibitors (statins) induce hepatic expression of the phospholipid translocase mdr2 in rats

Hooiveld, G. J. E. J., Vos, T. A., Scheffer, G. L., van Goor, H., Koning, H., Bloks, V. W., Loot, A. E., Meijer, D. K. F., Jansen, P. L. M., Kuipers, F., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70462-2 · Cited by 59 · see citing works

Effect of phenobarbital on the expression of bile salt and organic anion transporters of rat liver

Hagenbuch, N., Reichel, C., Stieger, B., Cattori, V., Fattinger, K. E., Landmann, L., Meier, P. J., & Kullak-Ublick, G. A. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00097-6 · Cited by 58 · see citing works

Urinary bile acids in late pregnancy and in recurrent cholestasis of pregnancy

Thomassen, P. A. B. (1979) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1979.tb00907.x · Cited by 56 · see citing works

Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells☆

Wagner, K., Peters, M., Scholz, A., Benckert, C., Ruderisch, H. S., Wiedenmann, B. J., & Rosewicz, S. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.03.011 · Cited by 42 · see citing works

Postnatal Expression and Induction by Pregnenolone-16α-Carbonitrile of the Organic Anion-Transporting Polypeptide 2 in Rat Liver

Guo, G. L., Johnson, D. R., & Klaassen, C. D. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.3.283 · Cited by 42 · see citing works

Experimental use of pravastatin in patients with primary biliary cirrhosis associated with hypercholesterolemia.

Kurihara, T., Akimoto, M., Abe, K., Ishiguro, H., Niimi, A., Maeda, A., Shigemoto, M., Yamashita, K., Yokoyama, I., & Suzuki, Y. (1993) · PubMed · Cited by 41 · see citing works

Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis

Marschall, H., Broomé, U., Einarsson, C., Alvélius, G., Thomas, H. G., & Matern, S. (2001) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)31635-7 · Cited by 37 · see citing works

Peroxisome Proliferator-Activated Receptor–α-/- Mice Show Enhanced Hepatocyte Proliferation in Response to the Hepatomitogen 1,4–Bis[2–(3,5–Dichloropyridyloxy)] Benzene, A Ligand of Constitutive Androstane Receptor

Columbano, A., Ledda‐Columbano, G. M., Pibiri, M., Concas, D., Reddy, J. K., & Rao, S. M. (2001) · Hepatology · doi:10.1053/jhep.2001.26172 · Cited by 35 · see citing works

Endoscopic ultrasound in the evaluation of Barrett's esophagus: a preliminary report.

Kamisako, T., & Adachi, Y. (1995) · PubMed · Cited by 17 · see citing works

70 Differential effects of ursodeoxycholic acid (UDCA) and cholic acid (CA) on hepatic and renal expression of MRP4 and MRP6, two novel ABC transporters, in mice

Zollner, G., Hallibasic, E., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Fuchsbichler, A., Zatloukal, K., Denk, H., & Trauner, M. A. (2004) · Journal of Hepatology · doi:10.1016/s0168-8278(04)90070-0 · Cited by 3 · see citing works

Gut microbiome and health: mechanistic insights

de Vos, W. M., Tilg, H., Van Hul, M., & Cani, P. D. (2022) · Gut · doi:10.1136/gutjnl-2021-326789 · Cited by 2,388 · see citing works

Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924 · see citing works

Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME

Godoy, P., Hewitt, N. J., Albrecht, U., Andersen, M. E., Ansari, N., Bhattacharya, S., Bode, J. G., Bolleyn, J., Borner, C., Böttger, J., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1078-5 · Cited by 1,280 · see citing works

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets

Fleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 577 · see citing works

Molecular physiology of bile acid signaling in health, disease, and aging

Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481 · see citing works

Bile acid transporters and regulatory nuclear receptors in the liver and beyond

Halilbasic, E., Claudel, T., & Trauner, M. A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.08.002 · Cited by 397 · see citing works

Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR

Tolson, A. H., & Wang, H. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.08.006 · Cited by 387 · see citing works

Role of Nuclear Receptors in the Adaptive Response to Bile Acids and Cholestasis: Pathogenetic and Therapeutic Considerations

Zollner, G., Marschall, H., Wagner, M., & Trauner, M. A. (2006) · Molecular Pharmaceutics · doi:10.1021/mp060010s · Cited by 334 · see citing works

The gut microbiota in obesity and weight management: microbes as friends or foe?

Hul, M. V., & Cani, P. D. (2023) · Nature Reviews Endocrinology · doi:10.1038/s41574-022-00794-0 · Cited by 335 · see citing works

Differential Regulation of Sinusoidal and Canalicular Hepatic Drug Transporter Expression by Xenobiotics Activating Drug-Sensing Receptors in Primary Human Hepatocytes

Jigorel, É., Vée, M. L., Boursier-Neyret, C., Parmentier, Y., & Fardel, O. (2006) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.010033 · Cited by 314 · see citing works

Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration

Geier, A., Wagner, M., Dietrich, C. G., & Trauner, M. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.04.014 · Cited by 313 · see citing works

Nuclear Receptor Coregulators and Human Disease

Lonard, D. M., Lanz, R. B., & O’Malley, B. W. (2007) · Endocrine Reviews · doi:10.1210/er.2007-0012 · Cited by 303 · see citing works

The role of bile acids in carcinogenesis

Režen, T., Rozman, D., Kovàcs, T., Kovács, P., Sipos, A., Bai, P., & Mikó, E. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04278-2 · Cited by 299 · see citing works

Nuclear receptors CAR and PXR: Molecular, functional, and biomedical aspects

di Masi, A., Marinis, E. D., Ascenzi, P., & Marino, M. (2009) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2009.04.002 · Cited by 288 · see citing works

New molecular insights into the mechanisms of cholestasis.

Wagner, M., Zollner, G., & Trauner, M. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.05.012 · Cited by 270 · see citing works

Coordinated Regulation of Hepatic Phase I and II Drug-Metabolizing Genes and Transporters using AhR-, CAR-, PXR-, PPARα-, and Nrf2-Null Mice

Aleksunes, L. M., & Klaassen, C. D. (2012) · Drug Metabolism and Disposition · doi:10.1124/dmd.112.045112 · Cited by 259 · see citing works

Bilirubin in the Liver–Gut Signaling Axis

Hamoud, A.-R. A., Weaver, L., Stec, D. E., & Hinds, T. D. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.01.002 · Cited by 257 · see citing works

Hepatocyte polarity

Treyer, A., & Müsch, A. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120009 · Cited by 252 · see citing works

Intestinal absorption of bile acids in health and disease

Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2019) · Comprehensive physiology · doi:10.1002/cphy.c190007 · Cited by 215 · see citing works

Statin therapy causes gut dysbiosis in mice through a PXR-dependent mechanism

Caparros-Martin, J. A., Lareu, R. R., Ramsay, J. P., Peplies, J., Reen, F. J., Headlam, H. A., Ward, N. C., Croft, K. D., Newsholme, P., Hughes, J., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0312-4 · Cited by 210 · see citing works

Effects of Perinatal PBDE Exposure on Hepatic Phase I, Phase II, Phase III, and Deiodinase 1 Gene Expression Involved in Thyroid Hormone Metabolism in Male Rat Pups

Szabo, D. T., Richardson, V. M., Ross, D. G., Diliberto, J. J., Kodavanti, P. R. S., & Birnbaum, L. S. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn230 · Cited by 208 · see citing works

Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener

Richardson, V. M., Staskal, D. F., Ross, D. G., Diliberto, J. J., DeVito, M. J., & Birnbaum, L. S. (2007) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2007.09.015 · Cited by 206 · see citing works

Targeting farnesoid X receptor for liver and metabolic disorders

Fiorucci, S., Rizzo, G., Donini, A., Distrutti, E., & Santucci, L. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.001 · Cited by 196 · see citing works

Systematic analysis of differential rhythmic liver gene expression mediated by the circadian clock and feeding rhythms

Weger, B. D., Gobet, C., David, F. P. A., Atger, F., Martín, E., Phillips, N. E., Charpagne, A., Weger, M., Naef, F., & Gachon, F. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2015803118 · Cited by 187 · see citing works

Coordinated induction of bile acid detoxification and alternative elimination in mice: role of FXR-regulated organic solute transporter-α/β in the adaptive response to bile acids

Zollner, G., Wagner, M., Moustafa, T., Fickert, P., Silbert, D., Gumhold, J., Fuchsbichler, A., Halilbasic, E., Denk, H., Marschall, H., et al. (2005) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00490.2005 · Cited by 180 · see citing works

Decoding the Role of CYP450 Enzymes in Metabolism and Disease: A Comprehensive Review

Abdelmonem, B. H., Abdelaal, N. M., Anwer, E. K. E., Rashwan, A. A., Hussein, M. A., Ahmed, Y. F., Khashana, R., Hanna, M. M., & Abdelnaser, A. (2024) · Biomedicines · doi:10.3390/biomedicines12071467 · Cited by 175 · see citing works

Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation

Hernandez, J., Mota, L. C., & Baldwin, W. S. (2009) · Current pharmacogenomics and personalized medicine (Online)/Current pharmacogenomics and personalized medicine · doi:10.2174/187569209788654005 · Cited by 159 · see citing works

Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice

Okada, K., Shoda, J., Taguchi, K., Maher, J. M., Ishizaki, K., Inoue, Y., Ohtsuki, M., Goto, N., Takeda, K., Utsunomiya, H., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90321.2008 · Cited by 149 · see citing works

Pregnane X Receptor Is a Target of Farnesoid X Receptor

Jung, D., Mangelsdorf, D. J., & Meyer, U. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600116200 · Cited by 145 · see citing works

Nuclear receptors as therapeutic targets in cholestatic liver diseases

Zollner, G., & Trauner, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2008.00030.x · Cited by 146 · see citing works

Role of bile acids in colon carcinogenesis

Nguyen, T. T., Ung, T. T., Kim, N. H., & Jung, Y. D. (2018) · World Journal of Clinical Cases · doi:10.12998/wjcc.v6.i13.577 · Cited by 143 · see citing works

Synthetic Drugs and Natural Products as Modulators of Constitutive Androstane Receptor (Car) and Pregnane X Receptor (PXR)

Chang, T. K. H., & Waxman, D. J. (2006) · Drug Metabolism Reviews · doi:10.1080/03602530600569828 · Cited by 143 · see citing works

Bile acids and their receptors: modulators and therapeutic targets in liver inflammation

Bertolini, A., Fiorotto, R., & Strazzabosco, M. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00935-7 · Cited by 142 · see citing works

Impaired uptake of conjugated bile acids and hepatitis b virus pres1‐binding in na+‐taurocholate cotransporting polypeptide knockout mice

Slijepcevic, D., Kaufman, C., Wichers, C. G. K., Gilglioni, E. H., Lempp, F. A., Duijst, S., de Waart, D. R., Elferink, R. P. J. O., Mier, W., Stieger, B., et al. (2015) · Hepatology · doi:10.1002/hep.27694 · Cited by 141 · see citing works

Evolution and Function of the NR1I Nuclear Hormone Receptor Subfamily (VDR, PXR, and CAR) with Respect to Metabolism of Xenobiotics and Endogenous Compounds

Reschly, E. J., & Krasowski, M. D. (2006) · Current Drug Metabolism · doi:10.2174/138920006776873526 · Cited by 140 · see citing works

MRP2 haplotypes confer differential susceptibility to toxic liver injury

Choi, J.-H., Ahn, B., Yi, J., Lee, J. H., Lee, J. H., Nam, S., Chon, C., Han, K., Ahn, S., Jang, I., et al. (2007) · Pharmacogenetics & Genomics · doi:10.1097/01.fpc.0000236337.41799.b3 · Cited by 150 · see citing works

Whatever Happened to “Neonatal Hepatitis”?

Balistreri, W. F., & Bezerra, J. A. (2006) · Clinics in Liver Disease · doi:10.1016/j.cld.2005.10.008 · Cited by 134 · see citing works

Liver resection for cancer: New developments in prediction, prevention and management of postresectional liver failure

van Mierlo, K. M. C., Schaap, F. G., Dejong, C. H. C., & Damink, S. W. M. O. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.06.006 · Cited by 130 · see citing works

Bile acid receptors and gastrointestinal functions

Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2019) · Liver Research · doi:10.1016/j.livres.2019.01.001 · Cited by 131 · see citing works

Hepatoprotective role of PXR activation and MRP3 in cholic acid‐induced cholestasis

Teng, S., & Piquette‐Miller, M. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707235 · Cited by 130 · see citing works

Rifaximin Is a Gut-Specific Human Pregnane X Receptor Activator

Ma, X., Shah, Y. M., Guo, G. L., Wang, T., Krausz, K. W., Idle, J. R., & Gonzalez, F. J. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.121913 · Cited by 127 · see citing works

Expression of bile acid synthesis and detoxification enzymes and the alternative bile acid efflux pump MRP4 in patients with primary biliary cirrhosis

Zollner, G., Wagner, M., Fickert, P., Silbert, D., Gumhold, J., Zatloukal, K., Denk, H., & Trauner, M. A. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01506.x · Cited by 126 · see citing works

Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease

Xie, C., Huang, W., Young, R. L., Jones, K. L., Horowitz, M., Rayner, C. K., & Wu, T. (2021) · Nutrients · doi:10.3390/nu13041104 · Cited by 124 · see citing works

Update on primary sclerosing cholangitis

Karlsen, T. H., & Boberg, K. M. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.03.015 · Cited by 123 · see citing works

Targeted Disruption of Murine Organic Anion-Transporting Polypeptide 1b2 (oatp1b2/Slco1b2) Significantly Alters Disposition of Prototypical Drug Substrates Pravastatin and Rifampin

Zaher, H., zu Schwabedissen, H. E. M., Tirona, R. G., Cox, M. L., Obert, L., Agrawal, N., Palandra, J., Stock, J. L., Kim, R. B., & Ware, J. A. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.046458 · Cited by 117 · see citing works

Perfluorooctanoic acid activates multiple nuclear receptor pathways and skews expression of genes regulating cholesterol homeostasis in liver of humanized PPARα mice fed an American diet

Schlezinger, J. J., Puckett, H. M., Oliver, J., Nielsen, G. H., Heiger‐Bernays, W., & Webster, T. F. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.115204 · Cited by 119 · see citing works

The Antiapoptotic Role of Pregnane X Receptor in Human Colon Cancer Cells

Zhou, J., Liu, M., Zhai, Y., & Xie, W. (2007) · Molecular Endocrinology · doi:10.1210/me.2007-0197 · Cited by 119 · see citing works

Update on primary sclerosing cholangitis

Karlsen, T. H., Schrumpf, E., & Boberg, K. M. (2010) · Digestive and Liver Disease · doi:10.1016/j.dld.2010.01.011 · Cited by 117 · see citing works

The Roles of Xenobiotic Receptors: Beyond Chemical Disposition

Mackowiak, B., Hodge, J., Stern, S., & Wang, H. (2018) · Drug Metabolism and Disposition · doi:10.1124/dmd.118.081042 · Cited by 116 · see citing works

The challenges of primary biliary cholangitis: What is new and what needs to be done

Terziroli Beretta-Piccoli, B., Mieli-Vergani, G., Vergani, D., Vierling, J. M., Adams, D., Alpini, G., Banales, J. M., Beuers, U., Björnsson, E., Bowlus, C., et al. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.102328 · Cited by 114 · see citing works

Importance of Hepatic Transporters in Clinical Disposition of Drugs and Their Metabolites

Patel, M., Taskar, K. S., & Zamek‐Gliszczynski, M. J. (2016) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.671 · Cited by 114 · see citing works

Lessons from the toxic bile concept for the pathogenesis and treatment of cholestatic liver diseases

Trauner, M. A., Fickert, P., Halilbasic, E., & Moustafa, T. (2008) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-008-0592-1 · Cited by 114 · see citing works

Nuclear Receptors as New Perspective for the Management of Liver Diseases

Trauner, M., & Halilbasic, E. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.044 · Cited by 114 · see citing works

Fxr−/− mice adapt to biliary obstruction by enhanced phase I detoxification and renal elimination of bile acids

Marschall, H., Wagner, M., Bodin, K., Zollner, G., Fickert, P., Gumhold, J., Silbert, D., Fuchsbichler, A., Sjövall, J., & Trauner, M. A. (2005) · Journal of Lipid Research · doi:10.1194/jlr.m500427-jlr200 · Cited by 112 · see citing works

Differentiation of mouse and human embryonic stem cells into hepatic lineages

Shiraki, N., Umeda, K., Sakashita, N., Takeya, M., Kume, K., & Kume, S. (2008) · Genes to Cells · doi:10.1111/j.1365-2443.2008.01201.x · Cited by 112 · see citing works

Targeting xenobiotic receptors PXR and CAR in human diseases

Banerjee, M., Robbins, D. F., & Chen, T. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.11.011 · Cited by 111 · see citing works

Sterolins ABCG5 and ABCG8: regulators of whole body dietary sterols

Hazard, S., & Patel, S. B. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-005-0040-7 · Cited by 105 · see citing works

Role of nuclear receptors for bile acid metabolism, bile secretion, cholestasis, and gallstone disease

Claudel, T., Zollner, G., Wagner, M., & Trauner, M. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.12.021 · Cited by 101 · see citing works

Nuclear Receptors as Drug Targets in Cholestatic Liver Diseases

Halilbasic, E., Baghdasaryan, A., & Trauner, M. A. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.12.001 · Cited by 98 · see citing works

Nuclear receptors CAR and PXR in the regulation of hepatic metabolism

Tien, E. S., & Negishi, M. (2006) · Xenobiotica · doi:10.1080/00498250600861827 · Cited by 97 · see citing works

Elevated hepatic multidrug resistance-associated protein 3/ATP-binding cassette subfamily C 3 expression in human obstructive cholestasis is mediated through tumor necrosis factor alpha and c-Jun NH2-terminal kinase/stress-activated protein kinase–signaling pathway

Chai, J., He, Y., Cai, S., Jiang, Z., Wang, H., Li, Q., Chen, L., Peng, Z., He, X., Wu, X., et al. (2011) · Hepatology · doi:10.1002/hep.24801 · Cited by 95 · see citing works

Variability in human hepatic MRP4 expression: influence of cholestasis and genotype

Gradhand, U., Lang, T., Schaeffeler, E., Glaeser, H., Tegude, H., Klein, K., Fritz, P., Jedlitschky, G., Kroemer, H. K., Bachmakov, I., et al. (2007) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500451 · Cited by 93 · see citing works

Expression of Hepatocyte Transporters and Nuclear Receptors in Children With Early and Late-Stage Biliary Atresia

Chen, H., Liu, Y., Chen, H., Wu, S., Ni, Y., Ho, M., Lai, H., Hsu, W., Hsu, H., Tseng, H.-C., et al. (2008) · Pediatric Research · doi:10.1203/pdr.0b013e318170a6b5 · Cited by 91 · see citing works

Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells

Lambert, C. B., Spire, C., Claude, N., & Guillouzo, A. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.11.008 · Cited by 90 · see citing works

Nuclear receptors as drug targets in cholestasis and drug-induced hepatotoxicity

Zollner, G., Wagner, M., & Trauner, M. A. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.03.005 · Cited by 89 · see citing works

Effect of Atorvastatin on the Pharmacokinetics and Pharmacodynamics of Prasugrel and Clopidogrel in Healthy Subjects

Farid, N. A., Small, D. S., Payne, C. D., Jakubowski, J. A., Brandt, J. T., Li, Y. G., Ernest, C. S., Salazar, D. E., Konkoy, C. S., & Winters, K. J. (2008) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.28.12.1483 · Cited by 89 · see citing works

Coordinated induction of drug transporters and phase I and II metabolism in human liver slices

Olinga, P., Elferink, M. G. L., Draaisma, A. L., Merema, M. T., Castell, J. V., Pérez, G., & Groothuis, G. M. M. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.01.008 · Cited by 88 · see citing works

Nuclear receptors as therapeutic targets in liver disease: are we there yet?

Rudraiah, S., Zhang, X., & Wang, L. (2016) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010715-103209 · Cited by 87 · see citing works

Life-Long Correction of Hyperbilirubinemia with a Neonatal Liver-Specific AAV-Mediated Gene Transfer in a Lethal Mouse Model of Crigler–Najjar Syndrome

Bortolussi, G., Zentillin, L., Jašprová, J., Bočkor, L., Bellarosa, C., Mancarella, A., Vianello, E., Tiribelli, C., Giacca, M., Vı́tek, L., et al. (2014) · Human Gene Therapy · doi:10.1089/hum.2013.233 · Cited by 86 · see citing works

Atorvastatin in patients with primary biliary cirrhosis and incomplete biochemical response to ursodeoxycholic acid

Stojaković, T., Putz‐Bankuti, C., Fauler, G., Scharnagl, H., Wagner, M., Stadlbauer, V., Gurakuqi, G. C., Stauber, R. E., März, W., & Trauner, M. A. (2007) · Hepatology · doi:10.1002/hep.21741 · Cited by 85 · see citing works

Nuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver

Staudinger, J. L., Woody, S. K., Sun, M., & Cui, W. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.748793 · Cited by 85 · see citing works

Small-molecule modulators of PXR and CAR

Chai, S. C., Cherian, M. T., Wang, Y., & Chen, T. (2016) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2016.02.013 · Cited by 85 · see citing works

The xenobiotic receptors PXR and CAR in liver physiology, an update

Cai, X., Young, G. M., & Xie, W. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166101 · Cited by 84 · see citing works

Molecular pathogenesis of Gilbert's syndrome: decreased TATA-binding protein binding affinity of UGT1A1 gene promoter

Hsieh, T., Shiu, T., Huang, S., Lin, H., Lee, T.-C., Chen, P., Chu, H.-C., Chang, W., Jeng, K.-S., Lai, M. M. C., et al. (2007) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328012d0da · Cited by 82 · see citing works

Vitamin D3 Modulates the Expression of Bile Acid Regulatory Genes and Represses Inflammation in Bile Duct-Ligated Mice

Ogura, M., Nishida, S., Ishizawa, M., Sakurai, K., Shimizu, M., Matsuo, S., Amano, S., Uno, S., & Makishima, M. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.145987 · Cited by 82 · see citing works

Mouse Organic Solute Transporter α Deficiency Enhances Renal Excretion of Bile Acids and Attenuates Cholestasis

Soroka, C. J., Mennone, A., Hagey, L. R., Ballatori, N., & Boyer, J. L. (2009) · Hepatology · doi:10.1002/hep.23265 · Cited by 80 · see citing works

Schisandrol B protects against cholestatic liver injury through pregnane X receptors

Zeng, H., Jiang, Y., Chen, P., Fan, X., Li, D., Liu, A., Ma, X., Xie, W., Liu, P., Gonzalez, F. J., et al. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13729 · Cited by 80 · see citing works

Bilirubin alone as a biomarker for short-term mortality in acute-on-chronic liver failure: an important prognostic indicator

López‐Velázquez, J. A., Chávez-Tapia, N. C., Ponciano‐Rodríguez, G., Sánchez-Valle, V., Caldwell, S. H., Uribe, M., & Méndez‐Sánchez, N. (2014) · Annals of Hepatology · doi:10.1016/s1665-2681(19)30910-x · Cited by 79 · see citing works

The antiepileptic and anticancer agent, valproic acid, induces P‐glycoprotein in human tumour cell lines and in rat liver

Eyal, S., Lamb, J. G., Smith-Yockman, M., Yagen, B., Fibach, E., Altschuler, Y., White, H. S., & Bialer, M. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706830 · Cited by 76 · see citing works

Targeted Drug Delivery to Treat Pain and Cerebral Hypoxia

Ronaldson, P. T., & Davis, T. P. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.005991 · Cited by 76 · see citing works

PXR Prevents Cholesterol Gallstone Disease by Regulating Biosynthesis and Transport of Bile Salts

He, J., Nishida, S., Xu, M., Makishima, M., & Xie, W. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.02.055 · Cited by 76 · see citing works

Constitutive Androstane Receptor-Mediated Changes in Bile Acid Composition Contributes to Hepatoprotection from Lithocholic Acid-Induced Liver Injury in Mice

Beilke, L. D., Aleksunes, L. M., Holland, R. D., Besselsen, D. G., Beger, R. D., Klaassen, C. D., & Cherrington, N. J. (2009) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.023317 · Cited by 73 · see citing works

Regulation of hepatic ABCC transporters by xenobiotics and in disease states

Gu, X., & Manautou, J. E. (2010) · Drug Metabolism Reviews · doi:10.3109/03602531003654915 · Cited by 73 · see citing works

Sirtuin 1 activation alleviates cholestatic liver injury in a cholic acid–fed mouse model of cholestasis

Kulkarni, S. R., Soroka, C. J., Hagey, L. R., & Boyer, J. L. (2016) · Hepatology · doi:10.1002/hep.28826 · Cited by 73 · see citing works

Organic Solute Transporter, OSTα-OSTβ: Its Role in Bile Acid Transport and Cholestasis

Soroka, C. J., Ballatori, N., & Boyer, J. L. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1253226 · Cited by 72 · see citing works

Metabolic preconditioning protects BSEP/ABCB11−/− mice against cholestatic liver injury

Fuchs, C. D., Paumgartner, G., Wahlstrom, A. M., Schwabl, P., Reiberger, T., Leditznig, N., Stojaković, T., Rohr‐Udilova, N., Chiba, P., Marschall, H., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.08.017 · Cited by 72 · see citing works

TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response

Zheng, M., Zhai, Y., Yu, Y., Shen, J., Chu, S., Focaccia, E., Tian, W., Wang, S., Liu, X., Yuan, X., et al. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2024.06.008 · Cited by 73 · see citing works

Polymorphisms in the Steroid and Xenobiotic Receptor Gene Influence Survival in Primary Sclerosing Cholangitis

Karlsen, T. H., Lie, B. A., Frøslie, K. F., Thorsby, E., Broomé, U., Schrumpf, E., & Boberg, K. M. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.05.057 · Cited by 71 · see citing works

The molecular pathogenesis of cholestasis in sepsis

Bhogal, H. K. (2012) · Frontiers in Bioscience-Elite · doi:10.2741/e598 · Cited by 69 · see citing works

A Concentration Addition Model for the Activation of the Constitutive Androstane Receptor by Xenobiotic Mixtures

Baldwin, W. S., & Roling, J. A. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn206 · Cited by 69 · see citing works

Short-chain chlorinated paraffins (SCCPs) induced thyroid disruption by enhancement of hepatic thyroid hormone influx and degradation in male Sprague Dawley rats

Gong, Y., Zhang, H., Geng, N., Xing, L., Fan, J., Luo, Y., Song, X., Ren, X., Wang, F., & Chen, J. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2017.12.251 · Cited by 67 · see citing works

Regulation of Transporters by Nuclear Hormone Receptors: Implications during Inflammation

Teng, S., & Piquette‐Miller, M. (2007) · Molecular Pharmaceutics · doi:10.1021/mp700102q · Cited by 68 · see citing works

Regulatory Pathways for ATP-binding Cassette Transport Proteins in Kidney Proximal Tubules

Masereeuw, R., & Rüssel, F. G. M. (2012) · The AAPS Journal · doi:10.1208/s12248-012-9404-z · Cited by 66 · see citing works

Molecular mechanisms of cholestasis

Zollner, G., & Trauner, M. A. (2006) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-006-0312-7 · Cited by 64 · see citing works

Nuclear factor-E2-related factor 2 is a major determinant of bile acid homeostasis in the liver and intestine

Weerachayaphorn, J., Mennone, A., Soroka, C. J., Harry, K., Hagey, L. R., Kensler, T. W., & Boyer, J. L. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00263.2011 · Cited by 62 · see citing works

The statin class of HMG-CoA reductase inhibitors demonstrate differential activation of the nuclear receptors PXR, CAR and FXR, as well as their downstream target genes

Howe, K., Sanat, F., THUMSER, A. E. A., Coleman, T., & Plant, N. J. (2011) · Xenobiotica · doi:10.3109/00498254.2011.569773 · Cited by 63 · see citing works

Differences in the Disposition of Silymarin between Patients with Nonalcoholic Fatty Liver Disease and Chronic Hepatitis C

Schrieber, S. J., Hawke, R. L., Wen, Z., Smith, P. C., Reddy, K. R., Wahed, A. S., Belle, S. H., Afdhal, N. H., Navarro, V. J., Meyers, C. M., et al. (2011) · Drug Metabolism and Disposition · doi:10.1124/dmd.111.040212 · Cited by 62 · see citing works

New insights in the biology of ABC transporters ABCC2 and ABCC3: impact on drug disposition

van der Schoor, L. W. E., Verkade, H. J., Kuipers, F., & Jonker, J. W. (2014) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2015.981152 · Cited by 62 · see citing works

Intestinal Absorption of Bile Acids in Health and Disease

Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K., & Alrefai, W. A. (2020) · Comprehensive physiology · doi:10.1002/j.2040-4603.2020.tb00108.x · Cited by 60 · see citing works

Effect of CAR activation on selected metabolic pathways in normal and hyperlipidemic mouse livers

Režen, T., Tamási, V., Lövgren‐Sandblom, A., Björkhem, I., Meyer, U., & Rozman, D. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-384 · Cited by 59 · see citing works

Nuclear receptors constitutive androstane receptor and pregnane X receptor ameliorate cholestatic liver injury

Stedman, C. A. M., Liddle, C., Coulter, S., Sonoda, J., Alvarez, J. G. A., Moore, D. D., Evans, R. M., & Downes, M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409794102 · Cited by 228 · see citing works

The Constitutive Androstane Receptor and Pregnane X Receptor Function Coordinately to Prevent Bile Acid-induced Hepatotoxicity

Zhang, J., Huang, W., Qatanani, M., Evans, R. M., & Moore, D. D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409041200 · Cited by 246 · see citing works

[Role of PXR and CAR in cholestasis].

Suh, J. I. (2006) · PubMed · Cited by 3 · see citing works

EFFECT OF PREGNANE X RECEPTOR (PXR) AND CONSTITUTIVE ANDROSTANE RECEPTOR (CAR) ON CYTOCHROME P3A ENZYMES IN AN EXPERIMENTAL MODEL OF CHOLESTASIS

DE MARTIN, S., Gabbia, D., Baldovin, T., LAZZARI, R., Mescoli, C., BALDO, V., & FLOREANI, A. (2014) · Padua Research Archive (University of Padova)

Xenobiotic-Sensing Nuclear Receptors CAR and PXR as Drug Targets in Cholestatic Liver Disease

Kakizaki, S., Takizawa, D., Tojima, H., Yamazaki, Y., & Mori, M. (2009) · Current Drug Targets · doi:10.2174/138945009789735174 · Cited by 24 · see citing works